Linked Parallel Synthesis and MTT Bioassay Screening of Substituted Chalcones

Journal of Combinatorial Chemistry

Volumn 3, Issue 5, 2001, Pages 421-426

  Lawrence, Nicholas J ^a,c   Rennison, David ^a,b   McGown, Alan T ^b   Ducki, Sylvie ^a,b   Gul, Lubna A ^a   Hadfield, John A ^b   Khan, Nader ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOPHENONE DERIVATIVE; ANTINEOPLASTIC AGENT; CHALCONE; DIAGNOSTIC AGENT; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ARTICLE; CELL CULTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG SCREENING; EVALUATION; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REPRODUCIBILITY; SYNTHESIS;

ACETOPHENONES; ANTINEOPLASTIC AGENTS; CHALCONE; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; REPRODUCIBILITY OF RESULTS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0035465012     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc000075z     Document Type: Article

References (42)

1. Terrett, N. K.; Gardner, M.; Gordon, D. W.; Kobylecki, R. J.; Steele, J. Tetrahedron 1995, 51, 8135-8173. Terrett, N. K.; Gardner, M.; Gordon, D. W.; Kobylecki, R. J.; Steele, J. Chem.-Eur. J. 1997, 3, 1917-1920.
2. Terrett, N. K.; Gardner, M.; Gordon, D. W.; Kobylecki, R. J.; Steele, J. Tetrahedron 1995, 51, 8135-8173. Terrett, N. K.; Gardner, M.; Gordon, D. W.; Kobylecki, R. J.; Steele, J. Chem.-Eur. J. 1997, 3, 1917-1920.
3. Maehr, H. Bioorg. Med. Chem. 1997, 5, 473-491.
4. Selway, C. N.; Terrett, N. K. Bioorg. Med. Chem. 1996, 4, 645-654.
5. Lam, K. S. Anti-Cancer Drug Des. 1997, 12, 145-167.
6. Partidos, C. D.; Chirinorojas, C. L.; Steward, M. W. Immunol. Lett. 1997, 57, 113-116.
7. Salmon, S. E.; Liu-Stevens, R. H.; Zhao, Y.; Lebl, M.; Krchnak, V.; Wertman, K.; Sepetov, N.; Lam, K. S. Mol. Diversity 1996, 2, 57-63.
8. Stratowa, C.; Baum, A.; Castanon, M. J.; Dahmann, G.; Himmelsbach, F.; Himmler, A.; Loeber, G.; Metz, T.; Schnitzer, R.; Solca, F.; Spevak, W.; Tontsch, U.; von Ruden, T. Anti-Cancer Drug Des. 1999, 14, 393-402.
9. Nicolaou, K. C.; Pfefferkorn, J.; Xu, J.-Y.; Winssinger, N.; Ohshima, T.; Kim, S. H.; Hosokawa, S.; Vouruloumis, D.; van Delft, F.; Li, T. Chem. Pharm. Bull. 1999, 47, 1199-1213. Nicolaou, K. C.; Winssinger, N.; Vourloumis, D.; Ohshima, T.; Kim, S.; Pfefferkorn, J.; Xu, J.-Y.; Li, T. J. Am. Chem. Soc. 1998, 120, 10814-10826.
10. Nicolaou, K. C.; Pfefferkorn, J.; Xu, J.-Y.; Winssinger, N.; Ohshima, T.; Kim, S. H.; Hosokawa, S.; Vouruloumis, D.; van Delft, F.; Li, T. Chem. Pharm. Bull. 1999, 47, 1199- 1213. Nicolaou, K. C.; Winssinger, N.; Vourloumis, D.; Ohshima, T.; Kim, S.; Pfefferkorn, J.; Xu, J.-Y.; Li, T. J. Am. Chem. Soc. 1998, 120, 10814-10826.
11. Nicolaou, K. C.; Winssinger, N.; Pastor, J.; Ninkovic, S.; Sarabia, F.; He, Y.; Vourloumis, D.; Yang, Z.; Li, T.; Giannakakou, P.; Hamel, E. Nature (London) 1997, 387, 268-272.
12. Salmon, S. E.; Lam, K. S.; Felder, S.; Yeoman, H.; Schlessinger, J.; Ullrich, A.; Krchnak, V.; Lebl, M. Int. J. Pharmacogn. 1995, 33, 67-74. Sandman, K. E.; Fuhrmann, P.; Lippard, S. J. J. Biol. Inorg. Chem. 1998, 3, 74-80.
13. Salmon, S. E.; Lam, K. S.; Felder, S.; Yeoman, H.; Schlessinger, J.; Ullrich, A.; Krchnak, V.; Lebl, M. Int. J. Pharmacogn. 1995, 33, 67-74. Sandman, K. E.; Fuhrmann, P.; Lippard, S. J. J. Biol. Inorg. Chem. 1998, 3, 74-80.
14. Edmondson, J. M.; Armstrong, L. S.; Martinez, A. O. J. Tissue Cult. Methods 1988, 11, 15-17.
15. Ducki, S.; Hadfield, J. A.; Hepworth, L. A.; Lawrence, N. J.; Liu, C.-Y.; McGown, A. T. Bioorg. Med. Chem. Lett. 1997, 7, 3091-3094. Ducki, S.; Hadfield, J. A.; Lawrence, N. J.; McGown, A. T.; Rennison, D. Bioorg. Med. Chem. Lett. 1998, 8, 1051-1056.
16. Ducki, S.; Hadfield, J. A.; Hepworth, L. A.; Lawrence, N. J.; Liu, C.-Y.; McGown, A. T. Bioorg. Med. Chem. Lett. 1997, 7, 3091-3094. Ducki, S.; Hadfield, J. A.; Lawrence, N. J.; McGown, A. T.; Rennison, D. Bioorg. Med. Chem. Lett. 1998, 8, 1051-1056.
17. Ikeda, S.; Kimura, U.; Ashizawa, T.; Gomi, K.; Saito, H. Jpn. Kokai Tokkyo Koho 1996, JP 08,188,546; Chem. Abstr. 1996, 125, 221359a.
18. Edwards, M. L.; Stemerick, D. M.; Sunkara, P. S. J. Med. Chem. 1990, 33, 1948-1954.
19. Pettit, G. R.; Singh, S. B.; Hamel, E.; Lin, C. M.; Alberts, D. S.; Garcia-Kendall, D. Experientia 1989, 45, 209-211.
20. For recent reports on the solution- and solid-phase synthesis of chalcone libraries for other purposes see the following. Powers, D. G.; Casebier, D. S.; Fokas, D.; Ryan, W. J.; Troth, J. R.; Coffen, D. L. Tetrahedron 1998, 54, 4085-4096. Marzinzik, A. L.; Felder, E. R. J. Org. Chem. 1998, 63, 723- 727. Katritzky, A. R.; Serdyuk, L.; Chassaing, C.; Toader, D.; Wang, X.; Forood, B.; Flatt, B.; Sun, C.; Vo, K. J. Comb. Chem. 2000, 2, 182-185.
21. For recent reports on the solution- and solid-phase synthesis of chalcone libraries for other purposes see the following. Powers, D. G.; Casebier, D. S.; Fokas, D.; Ryan, W. J.; Troth, J. R.; Coffen, D. L. Tetrahedron 1998, 54, 4085-4096. Marzinzik, A. L.; Felder, E. R. J. Org. Chem. 1998, 63, 723-727. Katritzky, A. R.; Serdyuk, L.; Chassaing, C.; Toader, D.; Wang, X.; Forood, B.; Flatt, B.; Sun, C.; Vo, K. J. Comb. Chem. 2000, 2, 182-185.
22. For recent reports on the solution- and solid-phase synthesis of chalcone libraries for other purposes see the following. Powers, D. G.; Casebier, D. S.; Fokas, D.; Ryan, W. J.; Troth, J. R.; Coffen, D. L. Tetrahedron 1998, 54, 4085-4096. Marzinzik, A. L.; Felder, E. R. J. Org. Chem. 1998, 63, 723- 727. Katritzky, A. R.; Serdyuk, L.; Chassaing, C.; Toader, D.; Wang, X.; Forood, B.; Flatt, B.; Sun, C.; Vo, K. J. Comb. Chem. 2000, 2, 182-185.
23. Controls for the aldehydes and ketones were not performed because we had previously found that those used were not cytotoxic. In principle, these could be performed by assessing the cytotoxicity at the same single value (5 μM) used for the library.
24. Random sampling of 32 wells revealed that 60% were essentially composed of only the expected chalcone; of the other 40% most were mixtures of the benzaldehyde, acetophenone, and chalcone.
25. Lawrence, N. J.; McGown, A. T.; Ducki, S.; Hadfield, J. A. Anti-Cancer Drug Des. 2000, 15, 135-141.
26. Woods, J. A.; Hadfield, J. A.; Pettit, G. R.; Fox, B. W.; McGown, A. T. Br. J. Cancer 1995, 71, 705-711.
27. Li, L.; Wang, H.-K.; Kuo, S.-C.; Wu, T.-S.; Mauger, A.; Lin, C. M.; Hamel, E.; Lee, K. H. J. Med. Chem. 1994, 37, 3400-3407.
28. Cushman, M.; Nagarathnam, D.; Gopal, D.; Chakraborti, A. K.; Lin, C. M.; Hamel, E. J. Med. Chem. 1991, 34, 2579-2588.
29. Grosios, K.; Holwell, S. E.; McGown, A. T.; Pettit, G. R.; Bibby, M. C. Br. J. Cancer 1999, 81, 1318-1327. Tozer, G. M.; Prise, V. E.; Wilson, J.; Locke, R. J.; Vojnovic, B.; Stratford, M. R. L.; Dennis, M. F.; Chaplin, D. J. Cancer Res. 1999, 59, 1626-1634. Dark, G. G.; Hill, S. A.; Prise, V. E.; Tozer, G. M.; Pettit, G. R.; Chaplin, D. J. Cancer Res. 1997, 57, 1829-1834. Landuyt, W.; Verdoes, O.; Darius, D. O.; Drijkoningen, M.; Nuyts, S.; Theys, J.; Stockx, L.; Wynendaele, W.; Fowler, J. F.; Maleux, G.; Van den Bogaert, W.; Anné, J.; van Oosterom, A.; Lambin, P. Eur. J. Cancer 2000, 36, 1833-1843.
30. Grosios, K.; Holwell, S. E.; McGown, A. T.; Pettit, G. R.; Bibby, M. C. Br. J. Cancer 1999, 81, 1318-1327. Tozer, G. M.; Prise, V. E.; Wilson, J.; Locke, R. J.; Vojnovic, B.; Stratford, M. R. L.; Dennis, M. F.; Chaplin, D. J. Cancer Res. 1999, 59, 1626-1634. Dark, G. G.; Hill, S. A.; Prise, V. E.; Tozer, G. M.; Pettit, G. R.; Chaplin, D. J. Cancer Res. 1997, 57, 1829-1834. Landuyt, W.; Verdoes, O.; Darius, D. O.; Drijkoningen, M.; Nuyts, S.; Theys, J.; Stockx, L.; Wynendaele, W.; Fowler, J. F.; Maleux, G.; Van den Bogaert, W.; Anné, J.; van Oosterom, A.; Lambin, P. Eur. J. Cancer 2000, 36, 1833-1843.
31. Grosios, K.; Holwell, S. E.; McGown, A. T.; Pettit, G. R.; Bibby, M. C. Br. J. Cancer 1999, 81, 1318-1327. Tozer, G. M.; Prise, V. E.; Wilson, J.; Locke, R. J.; Vojnovic, B.; Stratford, M. R. L.; Dennis, M. F.; Chaplin, D. J. Cancer Res. 1999, 59, 1626-1634. Dark, G. G.; Hill, S. A.; Prise, V. E.; Tozer, G. M.; Pettit, G. R.; Chaplin, D. J. Cancer Res. 1997, 57, 1829-1834. Landuyt, W.; Verdoes, O.; Darius, D. O.; Drijkoningen, M.; Nuyts, S.; Theys, J.; Stockx, L.; Wynendaele, W.; Fowler, J. F.; Maleux, G.; Van den Bogaert, W.; Anné, J.; van Oosterom, A.; Lambin, P. Eur. J. Cancer 2000, 36, 1833-1843.
32. Grosios, K.; Holwell, S. E.; McGown, A. T.; Pettit, G. R.; Bibby, M. C. Br. J. Cancer 1999, 81, 1318-1327. Tozer, G. M.; Prise, V. E.; Wilson, J.; Locke, R. J.; Vojnovic, B.; Stratford, M. R. L.; Dennis, M. F.; Chaplin, D. J. Cancer Res. 1999, 59, 1626-1634. Dark, G. G.; Hill, S. A.; Prise, V. E.; Tozer, G. M.; Pettit, G. R.; Chaplin, D. J. Cancer Res. 1997, 57, 1829-1834. Landuyt, W.; Verdoes, O.; Darius, D. O.; Drijkoningen, M.; Nuyts, S.; Theys, J.; Stockx, L.; Wynendaele, W.; Fowler, J. F.; Maleux, G.; Van den Bogaert, W.; Anné, J.; van Oosterom, A.; Lambin, P. Eur. J. Cancer 2000, 36, 1833-1843.
33. McGown, A. T.; Poppitt, D. G.; Swindell, R.; Fox, B. W. Cancer Chemother. Pharmacol. 1984, 13, 47-53.
34. McGown, A. T.; Jayson, G.; Pettit, G. R.; Haran, M. S.; Ward, T. H.; Crowther, D. Br. J. Cancer 1998, 77, 216-220.
35. Gutsche, C. D.; Jason, E. F.; Coffey, R. S.; Johnson, H. E. J. Am. Chem. Soc. 1958, 80, 5756-5767.
36. Mayer, W.; Bauni, G.; Stolp, F. Justus Liebigs Ann. Chem. 1960, 630, 19-25.
37. Silver, N. L.; Boykin, D. W., Jr. J. Org. Chem. 1970, 35, 759-764.
38. Li, R.; Kenyon, G. L.; Cohen, F. E.; Chen, X.; Gong, B.; Dominguez, J. N.; Davidson, E.; Kurzban, G.; Miller, R. E.; Nuzum, E. O.; Rosenthal, P.; McKerrow, J. H. J. Med. Chem. 1995, 38, 5031-5037.
39. Barnes, R. P.; Lucas, W. M. J. Am. Chem. Soc. 1942, 64, 2260-2261.
40. Kauffmann, H.; Kieser, F. Chem. Ber. 1913, 46, 3788-3801.
41. Belyaev, V. F. J. Gen. Chem. USSR (Engl. Transl.) 1964, 34, 856-858.
42. Fletcher, D. A.; McMeeking, R. F.; Parkin, D. J. J. Chem. Inf. Comput. Sci. 1996, 36, 746-749.